SELLAS Life Sciences Announces Preclinical Data Demonstrating SLS009 Synergy And Activity In MYC-Amplified Pancreatic Cancer Models
When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges - SELLAS Life Sci